[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
February 2, 2000

Gene Therapy Trials Show Clinical Efficacy

Author Affiliations

Not Available

Not Available

JAMA. 2000;283(5):589-590. doi:10.1001/jama.283.5.589

New Orleans—In the wake of the highly publicized and tragic death of a patient who participated in a gene therapy trial at the University of Pennsylvania comes some good news: encouraging early results from two studies reported here at the annual meeting of the American Society of Hematology, one aimed at a lethal form of inherited immunodeficiency and the other targeting hemophilia B.

If the promising but preliminary results from the two phase 1 trials hold up, the two studies may be the first to provide evidence of clinical benefit for patients treated with gene therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview